Company planning a demerger to unlock shareholders value ,as it is the only pharma company with lowest PE which is 10 , though company enjoys good revenue
Also keep an eye on 20 EMA
Can be bought for short time period
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.